335 related articles for article (PubMed ID: 36476351)
61. The malignant property of circHIPK2 for angiogenesis and chemoresistance in non-small cell lung cancer.
Ren M; Song X; Niu J; Tang G; Sun Z; Li Y; Kong F
Exp Cell Res; 2022 Oct; 419(2):113276. PubMed ID: 35863454
[TBL] [Abstract][Full Text] [Related]
62. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
63. Knockdown of Long Non-Coding RNA
Zhan Y; Abuduwaili K; Wang X; Shen Y; Nuerlan S; Liu C
Cancer Manag Res; 2020; 12():7725-7737. PubMed ID: 32943921
[TBL] [Abstract][Full Text] [Related]
64. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
[TBL] [Abstract][Full Text] [Related]
65. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.
Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L
Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120
[TBL] [Abstract][Full Text] [Related]
66. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
[TBL] [Abstract][Full Text] [Related]
67. miR-125b reverses cisplatin resistance by regulating autophagy via targeting RORA/BNIP3L axis in lung adenocarcinoma.
Liu L; Guo NA; Li X; Xu Q; He R; Cheng L; Dang C; Bai X; Bai Y; Wang X; Chen Q; Zhang LI
Oncol Res; 2024; 32(4):643-658. PubMed ID: 38560570
[TBL] [Abstract][Full Text] [Related]
68. Propofol decreases cisplatin resistance of non-small cell lung cancer by inducing GPX4-mediated ferroptosis through the miR-744-5p/miR-615-3p axis.
Han B; Liu Y; Zhang Q; Liang L
J Proteomics; 2023 Mar; 274():104777. PubMed ID: 36427803
[TBL] [Abstract][Full Text] [Related]
69. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.
Chen L; Han X; Hu Z; Chen L
Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368
[TBL] [Abstract][Full Text] [Related]
70. Mechanism of PWAR6 regulating cisplatin drug sensitivity in non-small cell lung cancer through miR-577/PHACTR1.
Tang W; Luo J; Lin S; Xu J; Yan Q
Gene; 2024 Jan; 893():147954. PubMed ID: 37923092
[TBL] [Abstract][Full Text] [Related]
71. Suppression of ZNF205-AS1/EGR4 positive feedback loop attenuates cisplatin resistance of non-small cell lung cancer cells via targeting miR-138-5p/OCT4 pathway.
Li H; Jin Y; Zhu Y; Shen B; Xu Y
J Thorac Dis; 2024 Jan; 16(1):296-310. PubMed ID: 38410545
[TBL] [Abstract][Full Text] [Related]
72. MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1.
Ma Y; Li X; Cheng S; Wei W; Li Y
Mol Med Rep; 2015 Jan; 11(1):625-32. PubMed ID: 25339370
[TBL] [Abstract][Full Text] [Related]
73. LINC02389/miR-7-5p Regulated Cisplatin Resistance of Non-Small-Cell Lung Cancer via Promoting Oxidative Stress.
Ma P; Han W; Meng C; Tan X; Liu P; Dong L
Anal Cell Pathol (Amst); 2022; 2022():6100176. PubMed ID: 36311891
[TBL] [Abstract][Full Text] [Related]
74. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.
Zheng S; Wang C; Yan H; Du Y
Bioengineered; 2021 Dec; 12(1):8347-8357. PubMed ID: 34592879
[TBL] [Abstract][Full Text] [Related]
75. Circ_0004015 silencing represses cisplatin chemoresistance and tumor progression by reducing KLF8 in a miR-198-dependent manner in non-small cell lung cancer.
Li Y; Yang X; Xiong X
Genomics; 2022 Mar; 114(2):110294. PubMed ID: 35134495
[TBL] [Abstract][Full Text] [Related]
76. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
Yao W; Guo P; Mu Q; Wang Y
Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
[No Abstract] [Full Text] [Related]
77. [The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain].
Ren L; Huang C; Liu YH; Yu Y; Lin L; Wen LJ
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1454-8. PubMed ID: 27266356
[TBL] [Abstract][Full Text] [Related]
78. miR-129-2 upregulation induces apoptosis and promotes NSCLC chemosensitivity by targeting SOX4.
Zhou W; Cai C; Lu J; Fan Q
Thorac Cancer; 2022 Apr; 13(7):956-964. PubMed ID: 35146917
[TBL] [Abstract][Full Text] [Related]
79. Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer.
Liu L; Zhang Q; Peng H
J Chemother; 2023 Feb; 35(1):39-52. PubMed ID: 35289739
[TBL] [Abstract][Full Text] [Related]
80. Knockdown of circLRWD1 weakens DDP resistance via reduction of SIRT5 expression through releasing miR-507 in non-small cell lung cancer.
Deng Z; Tu Q; Hu G; Xing M
Anticancer Drugs; 2022 Oct; 33(9):861-870. PubMed ID: 35946561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]